Medical

Free papers - Coagulation research, novel therapies, VWD, and surgical treatment

(FP-WE-01.4) Elevating Endogenous von Willebrand Factor (VWF) Levels: HMB-002 as a Prophylactic Treatment for Von Willebrand Disease (VWD)

Wednesday, April 23, 2025

4:00 PM - 4:15 PM GST

Location: Great Ballroom

Presenting Author(s)

Benny Sorensen, MD, PhD (he/him/his)

CEO
Hemab Therapeutics
Cambridge, United States